8
www.MarketResearchReports.com Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation Category : Diseases All logos and Images mentioned on this slide belong to their respective owners.

Alzheimer's Disease Therapeutics Market to 2019

Embed Size (px)

DESCRIPTION

As a result of Phase III therapy LMTX potentially entering the Alzheimer’s Disease (AD) industry in the near future, the AD market will increase slightly from $3.6 billion in 2012 to $3.8 billion in 2019. For more information visit: http://www.marketresearchreports.com/gbi-research/alzheimers-disease-therapeutics-market-2019-early-stage-innovation-points-disease

Citation preview

Page 1: Alzheimer's Disease Therapeutics Market to 2019

www.MarketResearchReports.com

Alzheimer's Disease

Therapeutics Market to 2019 -

Early Stage Innovation Points

to Disease Modifying

Therapies and Market

TransformationCategory : Diseases

All logos and Images mentioned on this slide belong to their respective owners.

Page 2: Alzheimer's Disease Therapeutics Market to 2019

www.MarketResearchReports.com

Introduction to Report

Launch Date: October 31, 2013

Number of Pages: 90

Geography Coverage: Global

Available Format: PDF

Price For Single User License: USD 3,500

Price For Site License: USD 7,000

Price For Global User License: USD 10,500

Delivery Time: Within 24 Hours (During Working Days)

Page 3: Alzheimer's Disease Therapeutics Market to 2019

www.MarketResearchReports.com

About the Report

The Alzheimer's Disease (AD) market is characterized by a lack of products with strong disease-modifying properties and a number of high-profile product failures in late stages of development over recent years. In addition, recent or impending patent expiries for all of the four currently marketed products and a late-stage pipeline with limited-to-moderate prospects are expected to impede growth over the next few years.

The Alzheimer’s Disease market will increase slightly from $3.6 billion in 2012 to $3.8 billion in 2019.

Page 4: Alzheimer's Disease Therapeutics Market to 2019

www.MarketResearchReports.com

Scope

A brief introduction to AD etiology, pathogenesis, diagnosis, and treatment regimes

Profiling of the marketed products in the AD market, including analysis of their safety, efficacy, treatment patterns, and strengths and weaknesses

Comprehensive review of the pipeline for AD therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market during the forecast period. The pipeline is analyzed on the basis of phase distribution, molecule type, and molecular target.

Additional in-depth analysis of pipeline drug clinical trials, analyzed by phase, molecule type, trial size, trial duration and program failure rate, for each molecule type and mechanism of action

Multi-scenario forecast data for the market to 2019, taking into account how it will be affected by the introduction of new drugs, the expiry of key patents on current drugs, and changes in disease epidemiology across the key developed markets of the US, Japan, Germany, the UK, France, Italy and Spain

Page 5: Alzheimer's Disease Therapeutics Market to 2019

www.MarketResearchReports.com

Reasons to Buy

Understand the different levels of AD therapies, from early-stage or mild AD to severe AD

Understand the vast scope of the pipeline, including which molecule types and mechanisms of action are prominent

Observe trends in terms of clinical trial duration and size among clinical phases and molecule types, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for AD therapeutics

Assess the potential clinical and commercial impact of current late-stage pipeline molecules on the AD therapeutics market

Page 6: Alzheimer's Disease Therapeutics Market to 2019

www.MarketResearchReports.com

Report Coverage

1. Marketed Products

2. Pipeline for Alzheimer's Disease Therapeutics

3. Market Forecast to 2019

4. Deals and Strategic Consolidations

For more details regarding Report coverage see the last slide

All logos and Images mentioned on this slide belong to their respective owners.

Page 7: Alzheimer's Disease Therapeutics Market to 2019

www.MarketResearchReports.com

Custom Research: Are you an industry professional, entrepreneur,

venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.

For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center

Page 8: Alzheimer's Disease Therapeutics Market to 2019

www.MarketResearchReports.com

How To Buy This Report?

Visit following URL to see Table of Content and purchase this publication:

http://www.marketresearchreports.com/gbi-research/alzheimers-disease-therapeutics-market-2019-early-stage-innovation-points-disease

About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.

Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)